Clark Estates »

Halozyme Therapeutics shares owned by Clark Estates

Quarter-by-quarter ownership of Halozyme Therapeutics (HALO) shares owned by Clark Estates from 13F filings

Historical chart of Clark Estates investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Clark Estates consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Clark Estates

Quarter filed Position value Share count Share price at filing
2025-09-30 $3.3M 45k 73.34
2025-06-30 $2.3M 45k 52.02
2025-03-31 $2.9M 45k 63.81
2024-12-31 $3.0M 62k 47.81